Optimal treatment of actinic keratoses
Elizabeth E UhlenhakeDepartment of Dermatology, Wayne State University School of Medicine, Detroit, MI, USAAbstract: The most compelling reason and primary goal of treating actinic keratoses is to prevent malignant transformation into invasive squamous cell carcinoma, and although there are well est...
Guardado en:
Autor principal: | |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/943bc03d39f347e9abcc32d20bd9a14e |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:943bc03d39f347e9abcc32d20bd9a14e |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:943bc03d39f347e9abcc32d20bd9a14e2021-12-02T02:45:26ZOptimal treatment of actinic keratoses1178-1998https://doaj.org/article/943bc03d39f347e9abcc32d20bd9a14e2013-01-01T00:00:00Zhttps://www.dovepress.com/optimal-treatment-of-actinic-keratoses-peer-reviewed-article-CIAhttps://doaj.org/toc/1178-1998Elizabeth E UhlenhakeDepartment of Dermatology, Wayne State University School of Medicine, Detroit, MI, USAAbstract: The most compelling reason and primary goal of treating actinic keratoses is to prevent malignant transformation into invasive squamous cell carcinoma, and although there are well established guidelines outlining treatment modalities and regimens for squamous cell carcinoma, the more commonly encountered precancerous actinic lesions have no such standard. Many options are available with variable success and patient compliance rates. Prevention of these lesions is key, with sun protection being a must in treating aging patients with sun damage as it is never too late to begin protecting the skin.Keywords: actinic keratosis, photodynamic therapy, topical chemotherapy, field therapyA Letter to the Editor has been received and published for this article.Uhlenhake EEDove Medical Pressarticleactinic keratosisphotodynamic therapytopical chemotherapyfield therapyGeriatricsRC952-954.6ENClinical Interventions in Aging, Vol Volume 8, Pp 29-35 (2013) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
actinic keratosis photodynamic therapy topical chemotherapy field therapy Geriatrics RC952-954.6 |
spellingShingle |
actinic keratosis photodynamic therapy topical chemotherapy field therapy Geriatrics RC952-954.6 Uhlenhake EE Optimal treatment of actinic keratoses |
description |
Elizabeth E UhlenhakeDepartment of Dermatology, Wayne State University School of Medicine, Detroit, MI, USAAbstract: The most compelling reason and primary goal of treating actinic keratoses is to prevent malignant transformation into invasive squamous cell carcinoma, and although there are well established guidelines outlining treatment modalities and regimens for squamous cell carcinoma, the more commonly encountered precancerous actinic lesions have no such standard. Many options are available with variable success and patient compliance rates. Prevention of these lesions is key, with sun protection being a must in treating aging patients with sun damage as it is never too late to begin protecting the skin.Keywords: actinic keratosis, photodynamic therapy, topical chemotherapy, field therapyA Letter to the Editor has been received and published for this article. |
format |
article |
author |
Uhlenhake EE |
author_facet |
Uhlenhake EE |
author_sort |
Uhlenhake EE |
title |
Optimal treatment of actinic keratoses |
title_short |
Optimal treatment of actinic keratoses |
title_full |
Optimal treatment of actinic keratoses |
title_fullStr |
Optimal treatment of actinic keratoses |
title_full_unstemmed |
Optimal treatment of actinic keratoses |
title_sort |
optimal treatment of actinic keratoses |
publisher |
Dove Medical Press |
publishDate |
2013 |
url |
https://doaj.org/article/943bc03d39f347e9abcc32d20bd9a14e |
work_keys_str_mv |
AT uhlenhakeee optimaltreatmentofactinickeratoses |
_version_ |
1718402179046309888 |